Accelerate Diagnostics is focused on developing and commercializing instrumentation for the identification and antibiotic susceptibility testing of infectious pathogens. Co.'s BACcel™ platform utilizes a culture-free process with both genomic and phenotypic detection technologies. The instrumentation uses automated digital microscopy to measure the responses of extracted live bacterial cells to various test conditions. These individual cells are analyzed to arrive at organism identification and antibiotic resistance characteristics. In addition, Co. has developed and licensed OptiChem surface coatings for use in microarraying components.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.